Physical Activity, Functional Capacity and Quality of Life in Older Patients With Chronic Comorbidities
NCT ID: NCT06535295
Last Updated: 2024-08-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
148 participants
OBSERVATIONAL
2024-01-01
2024-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physical Activity, Life Satisfaction and Medication Adherence in Older Adults
NCT06568822
The Effect of Exercise on Sleep Quality in Elderly Individuals
NCT07181460
Effects of Multicomponent Exercise on Quality of Life, Coping With Stress, and Well-Being in Older Women
NCT06849427
Physical Fitness in Elderly
NCT04250870
Physical Function From the Perspective of Active Ageing
NCT06733818
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Obesity, T2D, and HT can lead to complications in the cardiovascular and musculoskeletal systems, which in turn are likely to negatively affect PA, functional capacity, and QoL. For instance, obesity can increase the load on joints due to excessive weight, thereby restricting mobility, while T2D may adversely affect walking capacity through peripheral neuropathy and vascular complications. Hypertension could exacerbate symptoms during PA by increasing the cardiovascular load. In managing chronic diseases such as obesity, HT, and T2D, medications play a vital role in controlling these conditions and preventing complications. Nevertheless, even with this treatment, patients may continue to experience declines in functional capacity, PA, and QoL. The impact of chronic diseases such as obesity, HT, and T2D on PA, functional capacity, and QoL in older adults remains unclear in the literature. Although early detection and prevention of these conditions are important, the specific effects on these health aspects are not well-defined. Research indicates that while these conditions can influence health, their impact varies among individuals, and effective management may mitigate some adverse effects. Further research is needed to clarify how chronic diseases such as obesity, HT, and T2D affect PA, functional capacity, and QoL in the older population, as there remains a significant gap in empirical data regarding these effects.
Therefore, the aim of our study is to compare PA, functional capacity, and QoL between patients with obesity, HT, T2D, and healthy controls, and to elucidate the differing impacts of these chronic conditions on these parameters. The physical activity level will be evaluated using the short form of the International Physical Activity Questionnaire (IPAQ), the functional capacity will be evaluated using the 6-minute walk test, and the quality of life will be evaluated using the SF-36 Quality of Life Scale. At the end of the study, physical activity, functional capacity and quality of life will be compared between older patients with chronic comorbidities and healthy peers.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Obesity Group
Older patients with obesity
No interventions assigned to this group
Hypertension Group
Older patients with hypertension
No interventions assigned to this group
Type 2 Diabetes Group
Older patients with type 2 diabetes
No interventions assigned to this group
Healthy Group
Healthy older adults
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body Mass Index (BMI) ≥30 kg/m²
* Being 65 years of age or older
* Being diagnosed with hypertension
* Regular use of antihypertensive medication
* Being 65 years of age or older
* Being diagnosed with type 2 diabetes
* HbA1c levels: 57-78 mmol/mol (IFCC) or 7.4-9.3% (NGSP)
* Being 65 years of age or older
* Not having any chronic condition diagnosis
Exclusion Criteria
* Having a poor glycemic control
* Having a diabetic neuropathy
* Having a lower extremity musculoskeletal problem
* Having a balance disorder condition
* Having a cognitive impairment
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Biruni University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hikmet Ucgun
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hikmet Ucgun, PT, PhD
Role: PRINCIPAL_INVESTIGATOR
Atlas University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istanbul Atlas University
Istanbul, Kaguthane, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
auhucgun02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.